Richard J. Cornall
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Richard J. Cornall has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Andrew T. McKie
Department of Biochemistry and Nutrition Sciences Research Division, King's College London, London, United Kingdom
1 shared publicationAron Chakera
School of Medicine and Pharmacology, Sir Charles Gairdner Hospital, The University of Western Australia, 4th Floor G Block, Hospital Avenue, Nedlands, Perth, WA 6009, Australia
1 shared publication- Christopher C. Goodnow
Garvan Institute of Medical Research, Sydney, Australia
1 shared publication Dean R. Campagna
Department of Pathology, Children's Hospital and Harvard Medical School, Boston, MA
1 shared publicationGladys O. Latunde-Dada
Department of Biochemistry and Nutrition Sciences Research Division, King's College London, London, United Kingdom
1 shared publicationGuadalupe Villarreal
Department of Pathology, Children's Hospital and Harvard Medical School, Boston, MA
1 shared publication
Latest Publications
- Open Access
- 1 January 2012
- Published by Hindawi Limited in Journal of Immunology Research
- Vol. 2012, 1-10
The Phenotype of Circulating Follicular-Helper T Cells in Patients with Rheumatoid Arthritis Defines CD200 as a Potential Therapeutic Target
Rheumatoid arthritis (RA) is a systemic autoimmune disease primarily affecting synovial joints in which the development of autoantibodies represents a failure of normal tolerance mechanisms, suggesting a role for follicular helper T cells () in the genesis of autoimmunity. To determine whether quantitative or qualitative abnormalities in the circulatingcell population exist, we analysed by flow cytometry the number and profile of these cells in 35 patients with RA and 15 matched controls. Results were correlated with patient characteristics, including the presence of autoantibodies, disease activity, and treatment with biologic agents. Circulatingcells from patients with RA show significantly increased expression of the immunoglobulin superfamily receptor CD200, with highest levels seen in seropositive patients () and patients treated with anti-TNFαagents (). This occurs in the absence of any change innumbers or overt bias towards Th1, Th2, or Th17 phenotypes. CD200 levels did not correlate with DAS28 scores (). Although the number of circulatingcells is not altered in the blood of patients with RA, thecells have a distinct phenotype. These differences associatecells with the pathogenesis of RA and support the relevance of the CD200/CD200R signalling pathway as a potential therapeutic target.- 1 January 2012
- Published by Hindawi Limited in Journal of Immunology Research
- Vol. 2012, 1-10
Open AccessThe Phenotype of Circulating Follicular-Helper T Cells in Patients with Rheumatoid Arthritis Defines CD200 as a Potential Therapeutic Target
Rheumatoid arthritis (RA) is a systemic autoimmune disease primarily affecting synovial joints in which the development of autoantibodies represents a failure of normal tolerance mechanisms, suggesting a role for follicular helper T cells () in the genesis of autoimmunity. To determine whether quantitative or qualitative abnormalities in the circulatingcell population exist, we analysed by flow cytometry the number and profile of these cells in 35 patients with RA and 15 matched controls. Results were correlated with patient characteristics, including the presence of autoantibodies, disease activity, and treatment with biologic agents. Circulatingcells from patients with RA show significantly increased expression of the immunoglobulin superfamily receptor CD200, with highest levels seen in seropositive patients () and patients treated with anti-TNFαagents (). This occurs in the absence of any change innumbers or overt bias towards Th1, Th2, or Th17 phenotypes. CD200 levels did not correlate with DAS28 scores (). Although the number of circulatingcells is not altered in the blood of patients with RA, thecells have a distinct phenotype. These differences associatecells with the pathogenesis of RA and support the relevance of the CD200/CD200R signalling pathway as a potential therapeutic target. - Open Access
- 19 February 2009
- Published by American Society of Hematology in Blood
- Vol. 113 (8) , 1805-1808
Identification of a Steap3 endosomal targeting motif essential for normal iron metabolism
Hereditary forms of iron-deficiency anemia, including animal models, have taught us much about the normal physiologic control of iron metabolism. However, the discovery of new informative mutants is limited by the natural mutation frequency. To address this limitation, we have developed a screen for heritable abnormalities of red blood cell morphology in mice with single-nucleotide changes induced by the chemical mutagen ethylnitrosourea (ENU). We now describe the first strain, fragile-red, with hypochromic microcytic anemia resulting from a Y228H sub-stitution in the ferrireductase Steap3 (Steap3Y288H). Analysis of the Steap3Y288H mutant identifies a conserved motif required for targeting Steap3 to internal compartments and highlights how phenotypic screens linked to mutagenesis can identify new functional variants in erythropoiesis and ascribe function to previously unidentified motifs.
- 19 February 2009
- Published by American Society of Hematology in Blood
- Vol. 113 (8) , 1805-1808
Open AccessIdentification of a Steap3 endosomal targeting motif essential for normal iron metabolism
Hereditary forms of iron-deficiency anemia, including animal models, have taught us much about the normal physiologic control of iron metabolism. However, the discovery of new informative mutants is limited by the natural mutation frequency. To address this limitation, we have developed a screen for heritable abnormalities of red blood cell morphology in mice with single-nucleotide changes induced by the chemical mutagen ethylnitrosourea (ENU). We now describe the first strain, fragile-red, with hypochromic microcytic anemia resulting from a Y228H sub-stitution in the ferrireductase Steap3 (Steap3Y288H). Analysis of the Steap3Y288H mutant identifies a conserved motif required for targeting Steap3 to internal compartments and highlights how phenotypic screens linked to mutagenesis can identify new functional variants in erythropoiesis and ascribe function to previously unidentified motifs.